Angiosarcoma non-metastatic – Diagnostics – Overview of Information and Clinical Research

Angiosarcoma is a rare and aggressive cancer that begins in the cells lining blood vessels or lymph vessels, and diagnosing it early can make a significant difference in treatment outcomes. Understanding when to seek medical evaluation and what diagnostic tests are involved helps patients navigate this challenging journey with greater confidence.

Introduction: Who Should Undergo Diagnostics

Angiosarcoma is an uncommon type of cancer that develops in the inner lining of blood vessels and lymph vessels. Because it can appear almost anywhere in the body, knowing when to seek medical attention is important for catching the disease in its earlier stages. This cancer represents only about 1 to 2 percent of all soft tissue sarcomas, making it extremely rare. However, its aggressive nature means that prompt diagnosis is essential for better outcomes.^[1]

Anyone who notices unusual changes in their skin, particularly on the head, neck, or breast area, should consider consulting a healthcare provider. This is especially true if you see a bruise-like mark that doesn’t fade over time or seems to be growing larger. People who have previously received radiation therapy, which is treatment using high-energy rays to destroy cancer cells, face a higher risk of developing angiosarcoma years after their treatment. For example, women who underwent radiation for breast cancer may develop angiosarcoma on the chest wall approximately eight to ten years later.^[7]

Individuals with chronic swelling in the arms or legs, known as lymphedema, should also remain vigilant. This swelling happens when lymph fluid builds up in tissues, usually after cancer surgery or due to infection. People exposed to certain chemicals in their workplace, such as vinyl chloride, arsenic, or thorium dioxide, need to be aware that these substances increase their risk for developing angiosarcoma, sometimes not appearing until 10 to 40 years after exposure.^[7]

Elderly individuals, particularly those over 60 years old, should pay close attention to any skin changes on their scalp or face. The scalp is the most common location for angiosarcoma to develop, especially in older white men. If you notice a reddish or blue-colored lump that bleeds easily when bumped or scratched, or a purple area that looks like a rash or bruise but doesn’t heal, these are signals to seek medical evaluation immediately.^[2]

⚠️ Important

Don’t wait for symptoms to become severe before seeing a doctor. Angiosarcoma grows rapidly and spreads easily to other parts of the body, which is why early detection matters so much. Even if your symptoms seem minor, such as a small skin lesion that looks harmless, it’s better to have it checked by a healthcare professional than to delay and risk the cancer advancing to later stages.

Diagnostic Methods for Angiosarcoma

When angiosarcoma is suspected, doctors use several different approaches to confirm the diagnosis and understand the extent of the disease. The diagnostic process typically begins with a thorough physical examination where your doctor will look at and feel any lumps or unusual areas on your skin. They will ask about your medical history, including any past radiation treatments, chemical exposures, or chronic swelling you may have experienced.^[5]

Imaging Studies

Imaging tests create pictures of the inside of your body, helping doctors see the size and location of tumors. Ultrasound uses sound waves to produce images and is often one of the first tests performed. It’s particularly useful for examining tumors close to the skin surface or in organs like the breast or liver. The procedure is painless and doesn’t involve any radiation.^[5]

Computed tomography, commonly called a CT scan, uses X-rays taken from multiple angles to create detailed cross-sectional images of your body. This test helps doctors determine whether angiosarcoma has spread to internal organs or other areas beyond where it first appeared. During a CT scan, you lie still on a table that moves through a large ring-shaped machine. Sometimes a contrast dye is injected into your vein to make certain tissues show up more clearly in the images.^[5]

Magnetic resonance imaging, or MRI, uses powerful magnets and radio waves instead of X-rays to create detailed pictures of your body’s soft tissues. MRI scans are especially helpful for examining angiosarcomas in deeper tissues or organs because they provide excellent contrast between different types of tissue. Like CT scans, you’ll lie on a table that slides into a tube-shaped machine, and the test can take 30 to 60 minutes to complete.^[4]

Positron emission tomography, known as PET scan, involves injecting a small amount of radioactive sugar into your bloodstream. Cancer cells absorb more of this sugar than normal cells, causing them to light up on the scan images. PET scans are particularly valuable for detecting whether angiosarcoma has spread to distant parts of your body, such as the lungs or bones. Sometimes doctors combine PET with CT scans to get both functional and structural information in a single imaging session.^[4]

Biopsy: The Definitive Diagnostic Tool

While imaging tests provide important information about the location and size of suspected tumors, a biopsy is the only way to definitively diagnose angiosarcoma. During a biopsy, your doctor removes a small sample of tissue from the suspicious area. This sample is then sent to a laboratory where a specialist called a pathologist examines the cells under a microscope to determine if they are cancerous and what type of cancer is present.^[4]

There are different types of biopsies that doctors may use depending on where the suspected tumor is located. A needle biopsy involves inserting a thin needle into the tumor to withdraw a small amount of tissue. This is often done for tumors that can be felt through the skin or seen on imaging scans. For angiosarcomas on the skin, doctors may perform an incisional biopsy, where they use a surgical blade to remove a portion of the tumor, or an excisional biopsy, where they remove the entire visible tumor along with a small margin of surrounding tissue.^[6]

After the tissue sample is collected, pathologists perform special tests to confirm the diagnosis. Immunohistochemical testing involves applying specific stains to the tissue that react with certain proteins found in angiosarcoma cells. These tests help distinguish angiosarcoma from other types of cancer that might look similar under the microscope. The pathologist will also grade the tumor, which means describing how abnormal the cancer cells appear. Angiosarcomas are considered “high-grade” by definition, meaning they look very different from normal cells and tend to grow and spread quickly.^[1]

Additional Diagnostic Tests

Beyond imaging and biopsy, your medical team may order blood tests to check your overall health and look for markers that might indicate how your body is responding to the disease. While there isn’t a specific blood test that can diagnose angiosarcoma, blood work helps doctors assess your liver and kidney function, blood cell counts, and other factors that will be important when planning treatment.^[5]

When angiosarcoma affects the heart, which is extremely rare, doctors may use specialized tests like echocardiography. This test uses sound waves to create moving pictures of your heart, allowing doctors to see how well the heart is pumping and whether there are any masses growing inside the heart chambers. An electrocardiogram, or ECG, which records the electrical activity of your heart, might also be performed to check for abnormal heart rhythms.^[7]

For liver angiosarcoma, doctors may check for signs of liver damage through blood tests that measure liver enzymes and function. They’ll look for symptoms like yellowing of the skin and eyes, called jaundice, and pain in the upper part of the abdomen. Because angiosarcoma in internal organs often doesn’t cause symptoms until it grows quite large, these diagnostic tests become especially important for catching the disease before it advances too far.^[7]

Diagnostics for Clinical Trial Qualification

Clinical trials are research studies that test new treatments for diseases like angiosarcoma. These studies follow strict guidelines to ensure patient safety and to produce reliable results. Because of this, specific diagnostic tests and criteria are required before someone can enroll in a clinical trial. Understanding these requirements helps patients know what to expect if they’re considering participation in research studies.^[4]

Most clinical trials for angiosarcoma require thorough documentation of your diagnosis through biopsy results. The trial coordinators need to see pathology reports that confirm you have angiosarcoma and not another type of cancer. Some trials may require that tissue samples be reviewed by pathologists associated with the research center to verify the diagnosis according to their specific criteria. This second review, sometimes called a “central pathology review,” ensures that all participants truly have the disease being studied.^[5]

Clinical trials also typically require comprehensive imaging studies performed within a certain timeframe before enrollment, often within 4 to 6 weeks. These baseline scans, which usually include CT or MRI scans of the chest, abdomen, and pelvis, help researchers measure the size of your tumors before treatment begins. Later, they’ll repeat these scans at regular intervals to see whether the experimental treatment is working. This process of measuring tumor size over time is called “response assessment.”^[5]

Blood tests are another standard requirement for clinical trial qualification. Researchers need to know that your organs, especially your liver, kidneys, and bone marrow, are functioning well enough to handle the experimental treatment. Common blood tests include a complete blood count, which measures your red blood cells, white blood cells, and platelets, and comprehensive metabolic panel, which checks your liver and kidney function. Some trials have specific threshold values that your test results must meet.^[11]

Many clinical trials for non-metastatic angiosarcoma require staging information to determine whether the cancer has spread beyond its original location. Staging is a system that describes how much cancer is in your body and where it’s located. Doctors use the results from biopsies, imaging scans, and physical examinations to assign a stage. Stage 1 and 2 angiosarcomas are smaller and haven’t spread, while stage 3 means the cancer has begun growing into nearby tissues, and stage 4 indicates the cancer has spread to distant organs like the lungs or liver. Different clinical trials accept patients at different stages.^[6]

⚠️ Important

Clinical trials may also require genetic testing of your tumor tissue. Scientists have discovered that angiosarcomas can have mutations in certain genes, and some experimental treatments target these specific genetic changes. If you’re considering a clinical trial, ask your doctor whether genetic testing of your biopsy sample is needed and what those results might mean for your eligibility.

Performance status assessment is another common requirement for clinical trial enrollment. Doctors evaluate how well you can perform daily activities and take care of yourself. They use standardized scales to rate your ability to work, walk, eat, and carry out normal tasks. Trials may exclude patients whose cancer has made them too weak or sick, not because researchers don’t care, but because the experimental treatment might be too risky for someone in poor health.^[11]

Some clinical trials studying targeted therapies or immunotherapies require additional specialized tests on your tumor tissue. These might include tests that look for specific proteins on the surface of cancer cells or that measure how many immune cells are present in and around the tumor. For example, trials testing drugs that target vascular endothelial growth factor, or VEGF, which is a protein that helps tumors grow new blood vessels, may require tests showing that your tumor produces high levels of this protein.^[1]

Documentation of previous treatments is essential for most clinical trial applications. Researchers need to know exactly what therapies you’ve already received, including surgery, radiation, and chemotherapy. Some trials are specifically designed for patients who haven’t received any treatment yet, called “first-line” trials, while others are for patients whose cancer has returned after initial treatment, called “second-line” or “recurrent” trials. Your complete treatment history helps determine which trials might be appropriate for you.^[11]

For patients with non-metastatic angiosarcoma, clinical trials may require evidence that surgery can potentially remove all visible cancer. Surgeons work with radiologists to review imaging scans and determine whether complete surgical removal is feasible. This assessment involves measuring the tumor’s relationship to nearby vital structures and determining if removing it would leave you with acceptable function. Trials testing treatments given before surgery, called “neoadjuvant” therapy, especially need this type of surgical evaluation.^[11]

Prognosis and Survival Rate

Prognosis

The outlook for patients with angiosarcoma depends on several important factors. Where the cancer is located in your body plays a significant role in prognosis. Angiosarcomas that occur in the breast, particularly those that develop naturally rather than from radiation exposure, tend to have better outcomes than those appearing in other locations. The stage at which angiosarcoma is diagnosed is perhaps the most critical factor affecting prognosis. Patients whose cancer is caught early, when it’s still small and hasn’t spread beyond its original site, have much better chances of long-term survival compared to those diagnosed after the cancer has already spread to distant organs.^[9]

Age also influences how well patients do with this disease. Younger patients generally have better outcomes than older individuals, though angiosarcoma can be aggressive at any age. Secondary angiosarcoma, which develops as a complication of previous radiation therapy, tends to have a worse prognosis than primary angiosarcoma, which appears spontaneously. This difference appears to be driven by the fact that secondary angiosarcoma patients are typically older when diagnosed and their tumors often have more aggressive characteristics.^[9]

The grade of the tumor, which describes how abnormal the cancer cells look under a microscope, matters significantly. All angiosarcomas are considered “high-grade” by definition, meaning they naturally grow and spread quickly. However, even within this category, some tumors behave more aggressively than others. Whether surgeons can completely remove the cancer with clear margins, meaning no cancer cells are seen at the edges of the removed tissue, greatly affects the chance of the disease coming back.^[9]

Unfortunately, many angiosarcoma patients aren’t diagnosed until their cancer has already spread to other parts of the body. This late diagnosis contributes significantly to the overall poor prognosis associated with this disease. The reported rates of advanced or metastatic disease at the time of first diagnosis range from 16 to 44 percent of all angiosarcoma cases. When cancer spreads, treatment becomes much more challenging and the chances of long-term survival decrease substantially.^[5]

For patients with localized disease who undergo complete surgical removal, the risk of cancer returning remains high. Studies show that approximately 75 percent of recurrences happen within the first 24 months after initial treatment. The cancer often comes back at or near the original site, though it can also appear in distant organs like the lungs, liver, or bones. This high rate of recurrence reflects the aggressive nature of angiosarcoma and its tendency to spread through the bloodstream even when it appears to be confined to one area.^[8]

Survival Rate

Survival statistics for angiosarcoma vary considerably depending on the stage and location of the disease, but overall the numbers reflect its aggressive nature. For non-metastatic angiosarcoma, meaning cancer that hasn’t spread to distant organs, the five-year survival rate is approximately 35 percent. This means that about one-third of patients diagnosed with localized angiosarcoma are still alive five years after their diagnosis. However, these statistics represent averages from past cases and don’t account for newer treatments that are currently being developed.^[4]

Patients with primary breast angiosarcoma have notably better survival rates than those with angiosarcoma in other locations. Studies have found that the median overall survival for primary breast angiosarcoma patients is 93 months, which is nearly eight years. In contrast, patients with secondary breast angiosarcoma, which develops after radiation therapy, have a median overall survival of only 32 months, or just under three years. This substantial difference highlights how the underlying cause of angiosarcoma influences outcomes.^[9]

For patients diagnosed with metastatic angiosarcoma, meaning the cancer has already spread to other organs at the time of diagnosis, the prognosis is considerably worse. The median overall survival ranges from 6 to 16 months for metastatic disease. Some studies report a median survival of 6.9 months for patients with metastatic angiosarcoma compared to 20.4 months for those with localized disease. These stark differences underscore why early detection matters so much for this particular cancer.^[9]

Location-specific survival data shows that cutaneous angiosarcoma, particularly when it affects the scalp, carries an especially poor prognosis. Head and neck angiosarcomas tend to be diagnosed at more advanced stages and have a higher rate of spread to regional lymph nodes and distant organs. The median overall survival for patients with scalp angiosarcoma is often less than two years, even with aggressive treatment including surgery, radiation, and chemotherapy.^[15]

It’s important to understand that survival statistics are estimates based on large groups of patients and cannot predict exactly what will happen to any individual person. Many factors influence survival beyond just the statistics, including your overall health, how well you respond to treatment, and whether new therapeutic options become available. Additionally, these statistics often reflect outcomes from patients diagnosed several years ago and may not account for advances in treatment that have occurred more recently.^[4]

Some patients with angiosarcoma do achieve long-term survival, particularly those whose tumors are caught very early and completely removed with surgery. Small tumors that are removed with large surgical margins, meaning the surgeon takes out a significant amount of normal tissue around the cancer, have much better results. Patients who receive a combination of treatments including surgery, radiation therapy, and chemotherapy sometimes experience extended periods without disease, though the cancer can return even after many years.^[24]

#1 Clinical Trials Search in Europe